Patient Characteristics, Clinical Outcomes, and Effect of Dapagliflozin in Relation to Duration of Heart Failure Is It Ever Too Late to Start a New Therapy?

Review Cardiac & Cardiovascular Systems

Differences in clinical characteristics and outcome of de novo heart failure compared to acutely decompensated chronic heart failure - systematic review and meta-analysis

Raymond Pranata et al.

Summary: The clinical characteristics and outcomes of patients with de novo HF differ significantly from those with ADCHF, with de novo HF patients being younger, having lower prevalence of comorbidities, and experiencing lower mortality rates.

ACTA CARDIOLOGICA (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction Results From the DAPA-HF Trial

Mikhail N. Kosiborod et al.

CIRCULATION (2020)

Add to Collection

Article Cardiac & Cardiovascular Systems

A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF)

John J. McMurray et al.

EUROPEAN JOURNAL OF HEART FAILURE (2019)

Add to Collection

Article Cardiac & Cardiovascular Systems

Differences in Mortality of New-Onset (De-Novo) Acute Heart Failure Versus Acute Decompensated Chronic Heart Failure

Anan Younis et al.

AMERICAN JOURNAL OF CARDIOLOGY (2019)

Add to Collection

Article Cardiac & Cardiovascular Systems

The Dapagliflozin And Prevention of Adverse-outcomes in Heart Failure (DAPA-HF) trial: baseline characteristics

John J. V. McMurray et al.

EUROPEAN JOURNAL OF HEART FAILURE (2019)

Add to Collection

Article Medicine, General & Internal

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

J. J. V. McMurray et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Add to Collection

Article Cardiac & Cardiovascular Systems

Duration of chronic heart failure affects outcomes with preserved effects of heart rate reduction with ivabradine: findings from SHIFT

Michael Boehm et al.

EUROPEAN JOURNAL OF HEART FAILURE (2018)

Add to Collection

Article Cardiac & Cardiovascular Systems

Hospitalization for Recently Diagnosed Versus Worsening Chronic Heart Failure From the ASCEND-HF Trial

Stephen J. Greene et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)

Add to Collection

Article Cardiac & Cardiovascular Systems

Geographic variations in the PARADIGM-HF heart failure trial

Soren Lund Kristensen et al.

EUROPEAN HEART JOURNAL (2016)

Add to Collection

Review Cardiac & Cardiovascular Systems

Risk Prediction in Patients With Heart Failure A Systematic Review and Analysis

Kazem Rahimi et al.

JACC-HEART FAILURE (2014)

Add to Collection

Article Statistics & Probability

Semiparametric regression for the mean and rate functions of recurrent events

DY Lin et al.

JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY (2000)

Add to Collection

Patient Characteristics, Clinical Outcomes, and Effect of Dapagliflozin in Relation to Duration of Heart Failure Is It Ever Too Late to Start a New Therapy?

Related references

Export Citation

Share Paper